Johnson & Johnson
NYSE: JNJ
$145.27
+$0.80 (+0.6%)
Closing Price on December 23, 2024
JNJ Articles
These five very conservative Dividend Aristocrat stocks may offer nervous investors some shelter from the storm if markets head south again.
Published:
Here are 20 bold companies that have defied the odds by raising their dividends, after already knowing they were facing a very deep recession.
Published:
These five stocks could be big winners if the recovery is W-shaped and we and we return to the March lows before turning higher. They also have had substantial insider buying recently, a good sign...
Published:
Even in the toughest times, some companies still manage to generate dividend growth and prove that they have safe dividends. These 15 companies have announced dividend hikes in April.
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero Energy and Walt Disney.
Published:
These four top companies are raising dividends into one of the most unpredictable and volatile markets we have seen in years. For investors looking for ideas, these are all incredible companies that...
Published:
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and...
Published:
Johnson & Johnson released better than expected quarterly results and hiked its dividend before the markets opened on Tuesday.
Published:
Johnson & Johnson is scheduled to release its fiscal first-quarter financial results before the markets open on Tuesday.
Published:
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Johnson & Johnson and JPMorgan.
Published:
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Published:
Sometimes it's just the relative performance that really matters to investors. Imagine saying, "Gee, that's great because it's only down 10% in this awful stock market."
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published:
Investors have not shaved a tremendous amount of value from mega-cap public corporations. Two American companies still have market caps above $1 trillion.
Published:
Monday's blowout lows have more or less created a bear market on the average mega-cap stock. 24/7 Wall St. wanted to review the top 10 components of the S&P 500 Index by market capitalization to see...
Published: